Safely Manage Autoimmune Diseases

22110 Views
Was this article interesting to you?

Scientific Sources

What is paeoniflorin?

Most abundant and active glucoside in peony extract, responsible for much of medicinal benefits. Used to standardize formulations. Normalizes out-of-control immune system cells in autoimmune diseases. Promotes rebalance between inflammatory and anti-inflammatory cells. Accounts for pain-relieving properties.

Lupus flare reduction data?

Studies show peony glucosides used 5+ years dramatically reduce lupus flares to just 3%, compared with 19% in those using <5 years or intermittently, and 35% in those not using at all. Long-term use critical for sustained benefit.

Combined with standard drugs?

97.5% experienced at least some relief when treated with both peony glucosides and leflunomide (standard immunomodulatory drug), compared with 85% treated with drug alone. Combination therapy superior.

How many Americans affected?

Autoimmune diseases affect more than 23.5 million Americans (5-8% of population). Extremely painful and difficult to treat. Body turns on itself, launching relentless attack on own tissues. Resulting suffering often unimaginable.

Chinese FDA approval?

In China, peony glucosides are approved drug for treatment of rheumatoid arthritis (most common autoimmune arthritis). Recognized due to unique dual-acting mechanisms rebalancing malfunctioning immune system. Clinical trials involve RA, lupus, Sjogren's syndrome, psoriasis.

  • Paeoniflorin normalizes out-of-control immune cells maintaining inflammatory/anti-inflammatory balance
  • 3% lupus flares with 5+ years use vs 19% (<5 years) vs 35% (no use) - dramatic long-term benefit
  • 97.5% relief with peony + leflunomide vs 85% drug alone - combination superior
  • Dual-acting: suppresses harmful immune + boosts calming regulatory cells beyond what immunosuppressants achieve
  • Chinese State FDA approved drug for rheumatoid arthritis treatment
  • Rebalances inflammatory/anti-inflammatory cells through series of mechanisms
  • Sharply reduces inflammatory cytokine production breaking ever-increasing inflammation cycle
  • Pain relief: reduced joint swelling, scar tissue, bone/cartilage destruction in experimental arthritis
  • Slows maturation of pro-inflammatory cells while boosting regulatory cells returning immune to neutral
  • 23.5 million Americans (5-8%) suffer autoimmune diseases - peony offers safer alternative to dangerous drugs
  • Similar effectiveness to hydroxychloroquine for Sjogren's syndrome but vastly safer
  • Clinical trials: RA, lupus, Sjogren's, psoriasis - broad spectrum applications validated
  • Prevents joint-lining cells from becoming hyperinflammatory in RA - targets tissue level
  • Reduced auto-antibodies, increased salivary/tear flow in Sjogren's studies

Peony Glucoside Autoimmune Protocol

Step 1: Understand Autoimmune Disease Burden

Recognize 23.5 million Americans (5-8%) suffer from autoimmune conditions. Mainstream medicine has no cure. Conventional drugs costly, potentially dangerous, suppress entire immune system leaving vulnerable to infections and increased cancer risk.

Step 2: Assess Current Treatment Risks

If on immunosuppressants, understand risks: future infection vulnerability, cancer risk increase. Unlike these dangerous drugs, peony glucosides don't simply quash immune system but rebalance it.

Step 3: Paeoniflorin-Based Immune Rebalancing

Begin peony glucosides standardized to paeoniflorin (most abundant active compound). Normalizes out-of-control immune cells. In healthy person, cells maintain steady balance between inflammatory and anti-inflammatory stimuli - paeoniflorin restores this in autoimmune conditions.

Step 4: Dual-Acting Mechanism

Unlike immunosuppressants, peony simultaneously suppresses excessive harmful immune functions WHILE boosting calming regulatory cells. Slows maturation of pro-inflammatory cells, boosts regulatory cells returning system to normal neutral state. This level of immune balancing beyond what single-action drugs achieve.

Step 5: Inflammation Cycle Breaking

Through series of mechanisms, promotes rebalance between inflammatory and anti-inflammatory cells. Sharply reduces inflammatory cytokine production, breaks cycle of ever-increasing inflammation levels. Prevents joint-lining cells from becoming hyperinflammatory in rheumatoid arthritis.

Step 6: Combination Therapy Strategy

Studies show 97.5% experienced relief with peony + leflunomide vs 85% with drug alone. Consider combination with standard immunomodulatory drugs for superior outcomes. Chinese State FDA recognized as approved drug for rheumatoid arthritis.

Step 7: Long-Term Management for Maximum Benefit

Commit to 5+ years use for dramatic benefit. Lupus flare data: 3% flares with 5+ years use vs 19% (<5 years or intermittent) vs 35% (no use). Long-term use critical for sustained autoimmune control.

Step 8: Monitor Multiple Conditions

Clinical trials validated for: rheumatoid arthritis, lupus, Sjogren's syndrome, psoriasis. Broad spectrum applications. Pain relief includes reduced joint swelling, scar tissue, bone/cartilage destruction in experimental studies.

Step 9: Safety Advantage

Similar effectiveness to hydroxychloroquine for Sjogren's (reduced auto-antibodies, increased salivary/tear flow) but vastly safer. Multiple immuno-modulatory mechanisms. Explosion of scientific interest for safer autoimmune management.

  • Rheumatoid arthritis (ICD-10: M06.9 - Rheumatoid arthritis, unspecified)
  • Systemic lupus erythematosus (M32.9 - Systemic lupus erythematosus, unspecified)
  • Psoriasis and psoriatic arthritis (L40.9 - Psoriasis, unspecified; L40.50 - Arthropathic psoriasis)
  • Sjogren's syndrome (M35.00 - Sicca syndrome, unspecified)
  • Autoimmune disorders unspecified (M35.9 - Systemic involvement of connective tissue, unspecified)
  • Immune system dysfunction (D89.9 - Disorder involving immune mechanism, unspecified)
  • Those on dangerous immunosuppressants seeking safer alternative (Z79.899 - Other long term drug therapy)
  • Increased infection risk from current drugs (Z91.14 - Patient's other noncompliance with medication)
  • Increased cancer risk from immunosuppression (Z85.9 - Personal history of malignant neoplasm)
  • Over-excited immune system needing rebalancing without complete suppression
  • Part of 23.5 million Americans (5-8%) with autoimmune conditions
  • Long-term autoimmune management - 5+ years use shows dramatic lupus flare reduction
  • White peony/paeonia hypersensitivity
  • Pregnancy/breastfeeding without medical supervision
  • Children under 18 without pediatric rheumatologist guidance
  • Severe immunodeficiency (HIV/AIDS, severe combined immunodeficiency)
  • Active serious infections requiring different immediate treatment
  • Bleeding disorders - peony may have anticoagulant effects
  • Surgery scheduled within 2 weeks due to bleeding risk
  • Those on anticoagulants without monitoring

Paeoniflorin Active Compound: Peony extract contains specific glucosides. Most abundant and active glucoside is Paeoniflorin, responsible for much of medicinal benefits. Used to standardize formulation to specific amount. Normalizes out-of-control immune system cells that can be out of balance in autoimmune diseases. In healthy person, immune cells maintain steady balance between inflammatory and anti-inflammatory stimuli. However, in autoimmune diseases, numerous cells produce inflammatory chemicals resulting in chronic inflammation.

Lupus Flare Reduction - Long-Term Data: Studies show peony glucosides, when used for 5 years or more, can dramatically reduce rate of people experiencing lupus flares to just 3%, compared with 19% in those using supplement for less than 5 years or only intermittently, and 35% in those not using it at all. Long-term use demonstrates progressive benefit critical for sustained autoimmune control.

Combination Therapy Efficacy: Additional studies demonstrated that more people (97.5%) experienced at least some relief when treated with both peony glucosides and standard immunomodulatory drug leflunomide, compared with those treated with drug alone (85%). Combination therapy superior to monotherapy for achieving symptomatic relief.

Citation: Wang YN et al. The beneficial effect of Total Glucosides of Paeony on psoriatic arthritis links to circulating Tregs and Th1 cell function. Phytother Res. 2013 Apr 23.

Immune Rebalancing Mechanism: Through series of mechanisms, paeoniflorin promotes rebalance between inflammatory cells and calming anti-inflammatory cells. Rebalance sharply reduces production of inflammatory cytokines and breaks cycle of ever-increasing inflammation levels, especially in areas of body most vulnerable to autoimmune attack such as joints. Peony glucosides achieve immune balance by slowing maturation of cells promoting immune responses while boosting maturation of regulatory cells returning immune system to normal, neutral state. This level of immune balancing beyond what conventional immunosuppressants achieve.

Citations: Lin J et al. Total glucosides of paeony inhibits Th1/Th17 cells via decreasing dendritic cells activation in rheumatoid arthritis. Cell Immunol. 2012 Dec;280(2):156-63. | Zhou Z et al. Total glucosides of paeony attenuated functional maturation of dendritic cells via blocking TLR4/5 signaling in vivo. Int Immunopharmacol. 2012 Nov;14(3):275-82.

Chinese FDA Drug Recognition: In China, peony glucosides are approved drug for treatment of rheumatoid arthritis, most common autoimmune arthritis. Recognized due to ability to rebalance malfunctioning immune system through unique dual-acting mechanisms. To date peony glucosides have been used in clinical trials involving conditions such as rheumatoid arthritis, lupus, Sjogren's syndrome, psoriasis, and other lesser-known autoimmune conditions.

Citation: He DY, Dai SM. Anti-inflammatory and immunomodulatory effects of Paeonia lactiflora pall., a traditional chinese herbal medicine. Front Pharmacol. 2011 Feb 25;2:10.

Pain Relief and Tissue Protection: Paeoniflorin shown to account for many pain-relieving properties of peony glucosides. Studies of experimentally-induced arthritis in rats demonstrate reduced swelling and scar tissue in joints, along with decreases in bone and cartilage destruction - together, all these factors affect how much pain people feel from their arthritis. Dual action on both immune system and target tissues.

Citation: Chang Y et al. Effects and mechanisms of total glucosides of paeony on synoviocytes activities in rat collagen-induced arthritis. J Ethnopharmacol. 2009 Jan 12;121(1):43-8.

Sjogren's Syndrome Efficacy: Mouse studies reveal similar effectiveness between peony glucosides and immune-suppressive drug hydroxychloroquine (antimalarial drug used for Sjogren's syndrome), with prominent reductions in auto-antibodies and increases in salivary and tear flow rates - but peony root extract vastly safer and without drug side effects.

Autoimmune Disease Prevalence: Autoimmune diseases affect more than 23.5 million Americans (5 to 8% of population). Extremely painful and difficult to treat. In these conditions, body turns on itself, launching relentless attack on its own tissues. Resulting suffering often unimaginable. Mainstream medicine has no cure. Victims often injected with costly, potentially dangerous drugs suppressing immune system, leaving patient vulnerable to future infections and at increased risk for cancer.